checkAd

     257  0 Kommentare Nicox and Kowa Enter into Agreement for NCX 470 Development and Commercialization in Japan - Seite 3



    Nicox, headquartered in Sophia Antipolis, France, is listed on Euronext Growth Paris (Ticker symbol: ALCOX) and is part of the CAC Healthcare index.

    For more information www.nicox.com. Analyst coverage

    Bryan, Garnier & Co         Eric Yoo        Paris, France
    H.C. Wainwright & Co        Yi Chen        New York, U.S.   The views expressed by analysts in their coverage of Nicox are those of the author and do not reflect the views of Nicox. Additionally, the information contained in their reports may not be correct or current. Nicox disavows any obligation to correct or to update the information contained in analyst reports. Contacts  

    Nicox
    Gavin Spencer
    Executive Vice President, Chief Business Officer
    & Head of Corporate Development
    T +33 (0)4 97 24 53 00
    communications@nicox.com   Forward-Looking Statements The information contained in this document may be modified without prior notice. This information includes forward-looking statements. Such forward-looking statements are not guarantees of future performance. These statements are based on current expectations or beliefs of the management of Nicox S.A. and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Nicox S.A. and its affiliates, directors, officers, employees, advisers or agents, do not undertake, nor do they have any obligation, to provide updates or to revise any forward-looking statements.

    Risks factors which are likely to have a material effect on Nicox’s business are presented in section 2.7 of the “Rapport Annuel 2022” and in section 4 of the “Rapport semestriel financier et d’activité 2023” which are available on Nicox’s website (www.nicox.com). Nicox S.A.
    Sundesk Sophia Antipolis, Bâtiment C
    Emerald Square,
    Rue Evariste Galois, 06410 Biot, France
    T +33 (0)4 97 24 53 00

     

    Attachment


    Seite 3 von 3




    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Nicox and Kowa Enter into Agreement for NCX 470 Development and Commercialization in Japan - Seite 3 Press Release Nicox and Kowa Enter into Agreement for NCX 470 Development and Commercialization in Japan €3 million upfront payment and a total of a further potential €27.5 million in milestonesTiered royalties on net sales of 7% to 12%Kowa to be …